Analysts expect that CIGNA Co. (NYSE:CI) will post $2.52 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for CIGNA’s earnings, with estimates ranging from $2.44 to $2.59. CIGNA reported earnings per share of $1.94 during the same quarter last year, which suggests a positive year over year growth rate of 29.9%. The company is scheduled to issue its next earnings results on Thursday, February 7th.
On average, analysts expect that CIGNA will report full year earnings of $14.35 per share for the current financial year, with EPS estimates ranging from $14.29 to $14.43. For the next financial year, analysts expect that the business will report earnings of $16.55 per share, with EPS estimates ranging from $15.20 to $22.30. Zacks Investment Research’s EPS averages are an average based on a survey of analysts that follow CIGNA.
CIGNA (NYSE:CI) last posted its earnings results on Thursday, November 1st. The health services provider reported $3.84 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.45 by $0.39. CIGNA had a net margin of 6.15% and a return on equity of 23.31%. The firm had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.19 billion. During the same period last year, the firm posted $2.83 EPS. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis.
CIGNA stock opened at $224.84 on Tuesday. CIGNA has a 12-month low of $163.02 and a 12-month high of $227.13. The stock has a market cap of $54.40 billion, a price-to-earnings ratio of 21.50, a PEG ratio of 1.26 and a beta of 0.54. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.98 and a current ratio of 0.98.
In other CIGNA news, insider Michael W. Triplett sold 2,825 shares of CIGNA stock in a transaction that occurred on Monday, November 5th. The shares were sold at an average price of $214.25, for a total transaction of $605,256.25. Following the transaction, the insider now directly owns 23,871 shares of the company’s stock, valued at $5,114,361.75. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Jason D. Sadler sold 21,189 shares of CIGNA stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $212.99, for a total transaction of $4,513,045.11. Following the transaction, the insider now directly owns 41,966 shares in the company, valued at $8,938,338.34. The disclosure for this sale can be found here. Insiders sold 24,252 shares of company stock worth $5,164,402 over the last three months. Corporate insiders own 1.10% of the company’s stock.
A number of hedge funds have recently made changes to their positions in the business. Pennsylvania Trust Co raised its stake in shares of CIGNA by 1.2% during the third quarter. Pennsylvania Trust Co now owns 20,363 shares of the health services provider’s stock valued at $4,241,000 after purchasing an additional 245 shares during the period. Aviance Capital Partners LLC raised its stake in shares of CIGNA by 4.1% during the third quarter. Aviance Capital Partners LLC now owns 6,352 shares of the health services provider’s stock valued at $1,323,000 after purchasing an additional 250 shares during the period. Steward Partners Investment Advisory LLC raised its stake in shares of CIGNA by 8.7% during the third quarter. Steward Partners Investment Advisory LLC now owns 3,662 shares of the health services provider’s stock valued at $763,000 after purchasing an additional 292 shares during the period. Boston Financial Mangement LLC raised its stake in shares of CIGNA by 15.8% during the second quarter. Boston Financial Mangement LLC now owns 2,315 shares of the health services provider’s stock valued at $393,000 after purchasing an additional 315 shares during the period. Finally, Burney Co. raised its stake in shares of CIGNA by 1.5% during the second quarter. Burney Co. now owns 21,718 shares of the health services provider’s stock valued at $3,691,000 after purchasing an additional 318 shares during the period. 93.51% of the stock is currently owned by hedge funds and other institutional investors.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Further Reading: Diversification in Investing
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.